Heron Therapeutics Key Ratios (2010-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Profitability
Gross Margin (Quarter)	51.14%	47.03%	51.59%	41.46%	44.58%	57.95%	43.09%	36.53%	42.08%	71.12%	75.64%	70.80%	71.17%	74.92%	78.26%	73.50%	68.82%	72.61%	69.35%	69.28%
EBT Margin (Quarter)	-225.42%	-258.04%	-271.24%	-181.69%	-160.52%	-72.15%	-113.91%	-136.70%	-80.88%	-34.99%	-16.20%	-20.39%	-15.88%	9.97%	6.02%	-6.56%	-18.82%	-12.83%	-21.32%	-21.31%
EBIT Margin (Quarter)	-222.59%	-259.20%	-268.25%	-179.15%	-157.71%	-67.79%	-111.64%	-133.50%	-79.31%	-29.85%	-13.84%	-17.89%	-13.59%	10.23%	8.11%	-4.40%	-10.71%	0.09%	-13.73%	-5.43%
EBITDA Margin (Quarter)	-222.59%	-259.20%	-268.25%	-179.15%	-157.71%	-67.79%	-111.64%	-133.50%	-79.31%	-29.85%	-13.84%	-17.89%	-13.59%	10.23%	8.11%	-4.40%	-10.71%	0.09%	-13.73%	-5.43%
Operating Margin (Quarter)	-222.59%	-259.20%	-268.25%	-179.15%	-157.71%	-67.79%	-111.64%	-133.50%	-79.31%	-29.85%	-13.84%	-17.89%	-13.59%	10.23%	8.11%	-4.40%	-10.71%	0.09%	-13.73%	-5.43%
Net Margin (Quarter)	-225.42%	-258.04%	-271.24%	-181.69%	-160.52%	-72.15%	-113.91%	-136.70%	-80.88%	-34.99%	-16.20%	-20.39%	-15.88%	9.97%	6.02%	-6.56%	-18.82%	-12.83%	-21.32%	-21.31%
FCF Margin (Quarter)	-235.46%	-221.00%	-191.77%	-103.85%	-139.74%	-126.38%	-84.84%	-86.40%	-31.72%	6.44%	-27.45%	-12.78%	8.96%	-30.45%	-23.08%	-29.77%	3.48%	-22.63%	-5.56%	-6.24%
Efficiency
Inventory Average (Quarter)	42.15M	44.94M	52.43M	58.89M	56.78M	53.41M	53.32M	48.34M	43.31M	42.06M	21.11M	21.48M	44.41M	49.55M	55.05M	64.95M	71.50M	81.39M	92.64M	91.56M
Assets Average (Quarter)	378.32M	329.05M	289.71M	258.84M	257.96M	261.45M	235.91M	211.05M	215.21M	225.85M	220.20M	218.01M	219.46M	226.96M	234.45M	233.92M	240.52M	252.41M	251.05M	249.24M
Asset Utilization Ratio (Quarter)	0.23	0.26	0.31	0.37	0.38	0.41	0.48	0.56	0.57	0.56	0.60	0.63	0.63	0.64	0.63	0.64	0.64	0.61	0.60	0.61
Leverage & Solvency
Interest Coverage Ratio (Quarter)	-84.49	-117.41	-89.89	-70.71	-59.83	-15.09	-47.23	-42.40	-49.86	-5.77	-6.00	-7.16	-5.57	1.15	3.94	-2.05	-1.32	0.01	-1.81	-0.34
Debt Ratio (Quarter)									0.10	0.11	0.11	0.11	0.11	0.11	0.11		0.43	0.42	0.44	0.43
Times Interest Earned (Quarter)	-84.49	-117.41	-89.89	-70.71	-59.83	-15.09	-47.23	-42.40	-49.86	-5.77	-6.00	-7.16	-5.57	1.15	3.94	-2.05	-1.32	0.01	-1.81	-0.34
Valuation
Enterprise Value (Quarter)	-202.82M	-157.58M	-75.00M	-83.54M	-121.75M	-70.99M	-34.93M	-33.24M	-48.15M	-57.03M	-71.52M	-67.35M	-56.65M	-59.28M	-35.61M	-26.72M	-29.32M	-46.63M	-44.78M	-42.66M
Return Ratios
Return on Sales (Quarter)	-0.02%	-0.03%	-0.03%	-0.02%	-0.02%	-0.01%	-0.01%	-0.01%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Capital Employed (Quarter)	-73.72%	-66.31%	-116.23%	-145.75%	-126.67%	-97.52%	-91.64%	-110.76%	-89.14%	-49.07%	-56.86%	-33.69%	-19.36%	-5.10%	-2.45%	-4.99%	1.06%	-1.62%	-6.51%	-6.92%
Return on Assets (Quarter)	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Research Tools

Datasets

Plans

Developers

Heron Therapeutics HRTX Ratios (2010-2026)

Research Tools

Datasets

Plans

Developers

Heron Therapeutics HRTX Ratios (2010-2026)

Create an account

Sign In

Reset Password